Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Characteristics of bisphosphonate-related osteonecrosis of the jaw after kidney transplantation.

Park W, Lee SH, Park KR, Rho SH, Chung WY, Kim HJ.

J Craniofac Surg. 2012 Sep;23(5):e510-4. doi: 10.1097/SCS.0b013e31825b33f6.

PMID:
22976726
2.

Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.

Di Fede O, Fusco V, Matranga D, Solazzo L, Gabriele M, Gaeta GM, Favia G, Sprini D, Peluso F, Colella G, Vescovi P, Campisi G.

Eur J Intern Med. 2013 Dec;24(8):784-90. doi: 10.1016/j.ejim.2013.05.011.

PMID:
23768563
3.

Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation.

Then C, Hörauf N, Otto S, Pautke C, von Tresckow E, Röhnisch T, Baumann P, Schmidmaier R, Bumeder I, Oduncu FS.

Onkologie. 2012;35(11):658-64. doi: 10.1159/000343950.

PMID:
23147542
4.

Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.

Utreja A, Almas K, Javed F.

Odontostomatol Trop. 2013 Jun;36(142):38-46. Review.

PMID:
24073539
5.

Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.

López-Cedrún JL, Sanromán JF, García A, Peñarrocha M, Feijoo JF, Limeres J, Diz P.

Br J Oral Maxillofac Surg. 2013 Dec;51(8):874-9. doi: 10.1016/j.bjoms.2013.06.011.

PMID:
23866309
6.

The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.

Carlson ER, Basile JD.

J Oral Maxillofac Surg. 2009 May;67(5 Suppl):85-95. doi: 10.1016/j.joms.2009.01.006.

PMID:
19371819
7.
8.

Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?

Lescaille G, Coudert AE, Baaroun V, Javelot MJ, Cohen-Solal M, Berdal A, Goudot P, Azérad J, Ruhin B, Descroix V.

J Rheumatol. 2013 Jun;40(6):781-6. doi: 10.3899/jrheum.120810.

PMID:
23504384
9.
10.
11.

Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.

Grant BT, Amenedo C, Freeman K, Kraut RA.

J Oral Maxillofac Surg. 2008 Feb;66(2):223-30. doi: 10.1016/j.joms.2007.09.019.

PMID:
18201600
12.

A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.

Taylor T, Bryant C, Popat S.

Br Dent J. 2013 Apr;214(7):E18. doi: 10.1038/sj.bdj.2013.327.

PMID:
23579162
13.

Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.

Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, Hughes PJ, Michalowicz BS, Leach JW, Swenson KK, Swift JQ, Adkinson C, Basi DL.

J Oral Maxillofac Surg. 2009 Sep;67(9):1904-13. doi: 10.1016/j.joms.2009.04.051.

PMID:
19686928
14.

Oral health considerations in older women receiving oral bisphosphonate therapy.

Lo JC, O'Ryan F, Yang J, Hararah MK, Gonzalez JR, Gordon N, Silver P, Ansfield A, Wang B, Go AS.

J Am Geriatr Soc. 2011 May;59(5):916-22. doi: 10.1111/j.1532-5415.2011.03371.x.

PMID:
21539523
15.

Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.

Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J.

J Oral Maxillofac Surg. 2011 Nov;69(11):e364-71. doi: 10.1016/j.joms.2011.03.051.

PMID:
21782307
16.

Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris.

Maurer P, Sandulescu T, Kriwalsky MS, Rashad A, Hollstein S, Stricker I, Hölzle F, Kunkel M.

Int J Oral Maxillofac Surg. 2011 Mar;40(3):285-91. doi: 10.1016/j.ijom.2010.11.006.

PMID:
21163624
17.

Does dental and oral health influence the development and course of bisphosphonate-related osteonecrosis of the jaws (BRONJ)?

Krimmel M, Ripperger J, Hairass M, Hoefert S, Kluba S, Reinert S.

Oral Maxillofac Surg. 2014 Jun;18(2):213-8. doi: 10.1007/s10006-013-0408-3.

PMID:
23512234
18.

Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw: a case report and narrative review.

Thumbigere-Math V, Gopalakrishnan R, Michalowicz BS.

Northwest Dent. 2013 Jan-Feb;92(1):12-8. Review.

PMID:
23516715
19.

Bridging the gap between osteoporosis and osteonecrosis of the jaw: preventing and treating BRONJ with MK4.

Neustadt J, Pieczenik S.

Compend Contin Educ Dent. 2011 Oct;32(8):e125-31. Review.

PMID:
23738523
20.

Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.

Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N.

J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.

PMID:
20728033
Items per page

Supplemental Content

Support Center